ANRO vs PLUR โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ANRO Captures Institutional Edge (3โ1 Pillars ยท 7โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Alto Neuroscience Inc. (ANRO) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while PLUR counters with relative strength in Valuation. Fundamentally, ANRO trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus PLUR at 3.6x Forward P/E and -2454.5% operating margin (-15.8% YoY). In options structure, ANRO sits in BREAKDOWN (8th %ile IV; Dealer Gamma Walls on Pro) against PLUR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ANRO | PLUR | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.2B | $15.1M | Larger Scale | ANRO |
| Trailing P/E Ratio Valuation | N/M | 3.6x | Lower Multiple | PLUR |
| Forward P/E Ratio Valuation | N/M | 3.6x | Lower Multiple | PLUR |
| Revenue Growth (YoY) Growth | +0.0% | -15.8% | Higher Growth | ANRO |
| Operating Margin (TTM) Profitability | 0.0% | -2454.5% | Higher Margin | ANRO |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -46.7% | -1022.0% | Higher ROE | ANRO |
| 52-Week Range Position Momentum | 54% ($11โ$37) | 2% ($1โ$5) | Stronger Trend | ANRO |
| Beta / 30D Volatility Risk Regime | 2.03ฮฒ ยท 94% Vol | 0.80ฮฒ ยท 102% Vol | Lower Realized Risk | ANRO |
| Unified Institutional Score Composite Signal | 34.3 / 100 (SELL) | 28.8 / 100 (SELL) | Higher Composite | ANRO |